Debra Barker

Most recently Dr. Barker was Chief Medical and Development Officer of Polyphor during the period the company listed on the Swiss stock exchange. Prior to Polyphor, Dr. Barker held several senior roles at Novartis, including positions in oncology and infectious disease & immunology. She has also held several positions at Roche, including designing clinical studies for immunology drug development. She is currently on the board of the anti-infectives company Destiny Pharma and BerGenBio, an immuno-oncology company based in Norway. Dr. Barker received her medical training from Cambridge University, UK.